We used the hTau transgenic mouse, which overexpresses wild type human tau with a native promoter [125], and, to model AD, we used the triple transgenic rat (Swedish mutation in APP and mutation in presenilin-1 and presenilin-2) [126]. Here, MAPT is linked to Alzheimer disease.